Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Sicari
Use of Ceftolozane-Tazobactam in Patient With Severe Medium Chronic Purulent Otitis by XDR Pseudomonas Aeruginosa
Case Reports in Infectious Diseases
Related publications
Emergence of Ceftolozane-Tazobactam Resistant Pseudomonas Aeruginosa During Treatment Is Mediated by a Single AmpC Structural Mutation
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Treatment of Chronic Suppurative Otitis Media Infected With Pseudomonas Aeruginosa.
Practica Otologica
Otorhinolaryngology
Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas Aeruginosa Arising by AmpC- And Non-AmpC-Mediated Pathways”
Case Reports in Infectious Diseases
Long Term Compassionate Use of Cefiderocol to Treat Chronic Osteomyelitis Caused by XDR-Pseudomonas Aeruginosa and ESBL-producing Klebsiella Pneumoniae in a Pediatric Patient
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis
Case Reports in Obstetrics and Gynecology
Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Effect of Subinhibitory Concentration of Piperacillin/Tazobactam on Pseudomonas Aeruginosa
Journal of Medical Microbiology
Medicine
Microbiology
In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
